Patient Rating:

4.6 out of 5

121 Patient Ratings
64 Patient Comments

Nassir F. Marrouche, M.D.

Specialties

Languages

  • Arabic
  • English
  • German

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-7676 University Hospital
Cardiovascular Center
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

Dr. Marrouche has dedicated his career to developing innovative research and clinical practices to advance patient care, diagnosis and treatment of heart arrhythmias. In 2009, at the University of Utah, he created the Comprehensive Arrhythmia Research and Management Center (CARMA) bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists dedicated to working collaboratively to answer the questions: What if we treated patients proactively instead of reactively? Moreover, what if we could predict and prevent a stroke in a patient before it happens? Under the guidance of Dr. Marrouche, the CARMA Center developed the Utah Classification System enabling electrophysiologists and cardiologists to deliver individualized care to arrhythmia patients. In addition to presenting his work across the globe, he is the director of the Western Atrial Fibrillation Symposium.

Dr. Marrouche received his medical degree from the Medical School at the University of Heidelberg in Germany. Dr. Marrouche completed training in Internal Medicine and Cardiology at Klinikum Coburg, the teaching hospital of the University of Wurzburg in Germany. This was followed by a fellowship in Electrophysiology at the University of California, San Francisco. The Cleveland Foundation then offered a two-year fellowship in the Section of Pacing and Electrophysiology in the Department of Cardiovascular Medicine. After spending an additional three years at Cleveland Clinic a Associate Staff, he served as the Director of the Atrial Fibrillation Program at Klinikum Coburg for two years. Thereafter. he accepted a faculty position at the University of Utah serving as te Director of the EP Laboratories, Atrial Fibrillation Program, and later the Executive Director of the CARMA program.

Dr. Marrouche's research interests include the pathophysiology and new imaging modalities for treatment of atrial and ventricular arrhythmias.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.8
My confidence in care provider
4.8
Time care provider spent with me
4.3
Care provider spoke using clear language
4.7
Care provider's effort to include me in decisions
4.6
Care provider's concern for questions & worries
4.6
Care provider's explanation of condition/problem
4.5
Wait time at clinic
4.0
Care provider's friendliness and courtesy
4.7

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 25, 2014

awesome is dr. marrow he , wow

July 20, 2014

good

July 09, 2014

I have recommended and will continue to do it.

June 24, 2014

Considering I went back into atrial fibrillation while still in the hospital , I was very disappointed I didn't get to have a visit with Doctor Marrouche after my ablation.

June 13, 2014

have already referred Dr. Marrouche several times

May 24, 2014

Dr. Marrouche is an amazing physician. I am also a physician, and was impressed with his demeanor, his caring, his time spent to answer my questions and concerns.

May 23, 2014

I trust completely

April 23, 2014

Provider was in the room less than one minute.

April 22, 2014

Dr. Marrouche and the Pacemaker Specialist were both extremely professional, answered my questions and did a great job referring me to the correct MD.

April 16, 2014

It is great to be attended to by the BEST

March 29, 2014

Dr. Marrouche and especially Jessiciah Windfelder always show care and concern. Heather Margarats always respond fast and answer all questions.

March 14, 2014

very good!

March 13, 2014

Mister Nassir Marrouche, "Blessed Hands" is an XCLT, Professional, Friendly and Knowledgeable Doctor. My Wife enjoys her visits with Him (*__*)

February 14, 2014

The nurse practitioner seemed fairly knowledgeable.

February 12, 2014

I could have used a bit more information / details relative to the go forward plan for resolution of my condition.

February 06, 2014

good

January 26, 2014

Already have recommended Maroche

January 17, 2014

a very positive experience

December 10, 2013

He seems to be the best heart doctor one could have. He was very kind and compassionate.

October 26, 2013

complete satisfaction.

October 14, 2013

excellent consultation from NP Sara.

October 10, 2013

I have complete confidence in Dr. Marrouche and enjoy visiting with him.

August 28, 2013

we always say that we wish we lived closer to have the Dr care for me!

August 28, 2013

Dr M and your staff have provided me with 9 very good cardiac months and I am highly appreciative.

August 25, 2013

Highyly Recommended (*)__(*) Mr. Nassir Marrouche, aka "Mr. Wonderful", as My lovely Wife and I called Him, is a Very Professional, Friendly and Knowledgeable Doctor (O)__(O) He has completed three Ablation Procedures on My Wife (o?o) My Wife is Very happy because of it (0)_(0)

July 04, 2013

i recommend DR.Marrouche highly.

June 24, 2013

I highlay recommend Dr. Nassir Marrouche. His empathy with us was sincere. His skills and competency have proven to be extraordinary. Even he was deferential when told how exceptional his skills have proven to be. He is a particularly commendable asset to the hospital and his department.

June 04, 2013

Dr. Marouche is fabulous. He really wants to make sure you understand your problem(s) and the treatment he has planned. And, I think he's really worked on losing his accent as he's much easier to understand. :)

May 28, 2013

This has always been a great staff.

May 20, 2013

Dr M is a genius. Having to wait is not a factor that bothers me at all. He has followed my problems carefully and things are very much better since the ablation.

May 14, 2013

Always nice to talk with Dr. Marrouche, NP Jessiciah Winderfield or NP LeeAnn Williams

May 03, 2013

The best.

April 22, 2013

I am impressed with the entire staff and their professionalism

April 15, 2013

I would definitely recommend Dr. Marrouche and his staff.They are always professional, always up to date in their field and always respectful of the patient and their time!

March 12, 2013

I just need more explanation of the test given and future expectation.

February 12, 2013

Dr Marrouche and my Nurse Sara were both awesome! They were both all about business and making sure we get to the bottom of things. Overall great experience with the two.

January 14, 2013

Everyone was awesome. The nurse Melissa was exceptional. Jessiciah was particularly informative and knowledgeable

December 18, 2012

very good

November 26, 2012

The physician was in the room 5 minutes or less. He acted as though he was doing his job and nothing more. He was not at all friendly.

October 31, 2012

Would not dream of going to any other doctor for my heart problems. Have had bad experiences with others but never Dr. Marrouche.

October 29, 2012

I hope Dr. Marrouche is as good as he thinks he is. His bedside manner is rushed, strained, and one sided. I felt like I was imposing on his time.

October 23, 2012

I appreciate the conservative approach, and cessation of questionable medication prescribed by previoius caregiver.

October 18, 2012

Dr. Marouche and his staff are excellent and have treated me great!!!!

September 18, 2012

Very bad communicating

September 18, 2012

The care, concern and level of expertise in the cardiac clinic is exceptional

September 17, 2012

highly competant

September 10, 2012

the dr said he wanted to see me again in about 2 days, howerver the clinic made me an appoitment for 6 mo. I asked the clinic about the discrepincy, they said the dr is busy and doesn't really remember when he sees his patients.

August 13, 2012

We are incredibly happy with Dr Marrouche, and if we were answering this survey based solely on his care, the answers would have been all fives. We would recommend him to anyone, however each interaction we have had with Jessiciah has been ridiculous. She is condescending and unhelpful. She is unresponsive and difficult to work with, which interferes with treatment. Her actions at this visit directly impacted and delayed treatment by 2 days, and would have delayed it even further had another professional not intervened and corrected her errors. Her work was sloppy, and could have resulted in serious harm had it not been for a Pharmacist who caught her error, and spent 2 days trying to contact her to correct it.

August 13, 2012

Dr. Marrouche is an outstanding cardiologist he and his staff make sure you and your family understand fully what will take place. He is very caring and my husband loves to visit with him in arabic :)

July 23, 2012

good

June 11, 2012

Certainly, Dr. Marrouche is outstanding in his field and I appreciate that the University of Utah made such a service available. Please understand that I have the highest opinion greatest respect for Mr. Marrouche's skill and am grateful to have had him do my surgery. I probably would not be alive now without his knowledge and skill.

May 16, 2012

Love love love Dr. M and his staff. Only area for improvement is in coordinating scheduling of echo, MRI and next Dr. M visit -- needs nudging on my part to get that all done.

May 16, 2012

during my visits to UU I have been treated by MD's, PA's, NP's. ALL have been capable, compassionate, involved, and SMART

May 02, 2012

the best heart doctors in the state

May 02, 2012

very good

April 25, 2012

Have recommended Dr. Marrouche to several relatives and friends.

February 28, 2012

all were very informative instructive and understanding...me i was tired, irritable and hungry. everything was as it should be for any procedure. i have always had difficulties being patient ..thank you

February 22, 2012

Excellent visit-- friendly and helpful.

February 22, 2012

The attending had the worst bedside manner I have ever experienced. He saw me for less then 3 minutes--- asked me several questions about my medical history without letting me respond. Told me the additional test he wanted and that he would call with the results. Then told me to have a nice day and left the room. I was never able to answer the questions he asked me nor able to ask him anything. He also said he disagreed with his fellow and that we would proceed how he wanted. I felt it was completely inappropriate to challenge his fellow in front of a patient and left me uncertain of who was the better judge of my condition-- the fellow who actually took the time to see me, but had less training, or the attending who had more training and spent no time even assessing my case? I would never return to see this doctor and I would never recommend him. When I go to the doctor, I expect to have to wait a long time and I expect to see the doctor very little. But this experience was far worse than any other I have had.

February 08, 2012

Every one at the hospital was very professional and did a good job of taking care of me.

February 01, 2012

I always felt that they were genuinely concerned.

January 25, 2012

I was a little frustrated that I had specifically asked my provider if I should wear a holter when I was having palpitations, was told to just take my meds, and the resolution at my appointment was to wear the monitor. I could have had it done and been able to see the results by now.

January 11, 2012

We have had good exeperiences every time we meet with the doctors in cardiology.

January 04, 2012

I have recommended the provider to my friends.

Academic Profile

Research Interests

  • Atrial Fibrillation
  • Interventional MRI
  • Experimental Transgenic Models
  • Advanced MRI Imaging
  • Development of techniques for imaging and analysis of 3D cardiac fields

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-2572 School of Medicine
Division of Cardiology
30 N Medical Dr
Salt Lake City, UT 84132
(801) 585-7676 University Hospital
Cardiology
50 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Dr. Marrouche has dedicated his career to developing innovative research and clinical practices to advance patient care, diagnosis and treatment of heart arrhythmias. In 2009, at the University of Utah, he created the Comprehensive Arrhythmia Research and Management Center (CARMA) bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists dedicated to working collaboratively to answer the questions: What if we treated patients proactively instead of reactively? Moreover, what if we could predict and prevent a stroke in a patient before it happens? Under the guidance of Dr. Marrouche, the CARMA Center developed the Utah Classification System enabling electrophysiologists and cardiologists to deliver individualized care to arrhythmia patients. In addition to presenting his work across the globe, he is the director of the Western Atrial Fibrillation Symposium.

Dr. Marrouche received his medical degree from the Medical School at the University of Heidelberg in Germany. Dr. Marrouche completed training in Internal Medicine and Cardiology at Klinikum Coburg, the teaching hospital of the University of Wurzburg in Germany. This was followed by a fellowship in Electrophysiology at the University of California, San Francisco. The Cleveland Foundation then offered a two-year fellowship in the Section of Pacing and Electrophysiology in the Department of Cardiovascular Medicine. After spending an additional three years at Cleveland Clinic a Associate Staff, he served as the Director of the Atrial Fibrillation Program at Klinikum Coburg for two years. Thereafter. he accepted a faculty position at the University of Utah serving as te Director of the EP Laboratories, Atrial Fibrillation Program, and later the Executive Director of the CARMA program.

Dr. Marrouche's research interests include the pathophysiology and new imaging modalities for treatment of atrial and ventricular arrhythmias.

Education

Education History

Type School Degree
Fellowship Cleveland Clinic Foundation
Electrophysiology
Fellow
Fellowship University of California
Electrophysiology
Fellow
Residency Klinikum Coburg
Internal Medicine/Cardiology
Resident
Professional Medical University of Heidelberg
Medicine
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI.McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS, Marrouche NF (2014). Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol, 7(1), 23-30.
  2. Comparison of Left Atrial Area Marked Ablated in Electroanatomical Maps with Scar in MRI.LID - 10.1111/jce.12357 [doi]Parmar BR, Jarrett TR, Burgon NS, Kholmovski EG, Akoum NW, Hu N, Macleod RS, Marrouche NF, Ranjan R (2014). Comparison of Left Atrial Area Marked Ablated in Electroanatomical Maps with Scar in MRI.LID - 10.1111/jce.12357 [doi]. J Cardiovasc Electrophysiol.
  3. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J (2014). Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA, 311(5), 498-506.
  4. The effect of fat pad modification during ablation of atrial fibrillation: late gadolinium enhancement MRI analysis.Higuchi K, Akkaya M, Koopmann M, Blauer JJ, Burgon NS, Damal K, Ranjan R, Kholmovski E, Macleod RS, Marrouche NF (2013). The effect of fat pad modification during ablation of atrial fibrillation: late gadolinium enhancement MRI analysis. Pacing Clin Electrophysiol, 36(4), 467-76.
  5. Rapid ungated myocardial perfusion cardiovascular magnetic resonance: preliminary diagnostic accuracy.Harrison A, Adluru G, Damal K, Shaaban AM, Wilson B, Kim D, McGann C, Marrouche NF, Dibella EV (2013). Rapid ungated myocardial perfusion cardiovascular magnetic resonance: preliminary diagnostic accuracy. J Cardiovasc Magn Reson, 15(1), 26.
  6. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K, Kholmovski E, McGann C, Marrouche NF (2013). Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace.
  7. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant.Akoum N, McGann C, Vergara G, Badger T, Ranjan R, Mahnkopf C, Kholmovski E, Macleod R, Marrouche N (2012). Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol, 23(1), 44-50.
  8. R Ranjan, E Kholmovski, J Blauer, S Vijayakumar, N Volland, M Salama, D Parker, R MacLeod, N Marrouche (2012). Identification and Acute Targeting of Gaps in Atrial Ablation Lesion Sets Using a Real-Time Magnetic Resonance Imaging System. 10.1161/CIRCEP.112.973164 [doi]. Circ Arrhythm Electrophysiol, 5(6), 1130-1135.
  9. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach.Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N (2011). Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol, 22(1), 16-22.
  10. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation.Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G, Kholmovski E, McGann CJ, Parker D, Brachmann J, Macleod RS, Marrouche NF (2011). Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol, 57(7), 831-8.
  11. Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation.McGann C, Kholmovski E, Blauer J, Vijayakumar S, Haslam T, Cates J, DiBella E, Burgon N, Wilson B, Alexander A, Prastawa M, Daccarett M, Vergara G, Akoum N, Parker D, MacLeod R, Marrouche N (2011). Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation. J Am Coll Cardiol, 58(2), 177-85.
  12. Three-dimensional late gadolinium enhancement imaging of the left atrium with a hybrid radial acquisition and compressed sensing.Adluru G, Chen L, Kim SE, Burgon N, Kholmovski EG, Marrouche NF, Dibella EV (2011). Three-dimensional late gadolinium enhancement imaging of the left atrium with a hybrid radial acquisition and compressed sensing. J Magn Reson Imaging, 34(6), 1465-71.
  13. Vergara GR, Vijayakumar S, Kholmovski EG, Blauer JJ, Guttman MA, Gloschat C, Payne G, Vij K, Akoum NW, Daccarett M, McGann CJ, Macleod RS, Marrouche NF (2011). Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm, 8(2), 295-303.
  14. Vergara GR, McMullan L, Marrouche NF (2011). Right atrial perforation at the end of an atrial fibrillation ablation procedure. doi: 10.1093/europace/eur006©. Europace, 13(6), 901-2.
  15. Catheter ablation treatment for paroxysmal atrial fibrillation results in a longer time to treatment failure than anti-arrhythmic drugs and improves quality of life.Marrouche NF (2010). Catheter ablation treatment for paroxysmal atrial fibrillation results in a longer time to treatment failure than anti-arrhythmic drugs and improves quality of life. Evid Based Med, 15(3), 88-9.
  16. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AF Trial Investigators Collaborators Wilber D, Akar J, Santucci P, Schneck M, Finn C, Pappone C, Augello G, Sala S, Neuzil P, Reddy V, Coling L, Kanova M, Kralovec S, Kruger A, Kupec J, Petru J, Sediva L, Sidova M, Skoda J, Taborsky M, de Paola A, Brito Rde J, da Costa PA, Dalegrave C, Dietrich C, Ferro CR, Hernandes V, Horbach SJ, Marchlinski F, Bala R, Cooper J, Dixit S, Garcia F, Gerstenfeld E, Gnap M, Hsia H, Killian T, Lin D, Russo A, Schott G, Verdino R, Zado E, Natale A, Wazni O, Bhargava M, Arruda M, Burkhardt JD, Chung M, Cross J, Dressing T, Elliott K, Fariello C, Castle LW, Cummings JE, Holmes D, Jaeger FJ Jr, Jarosz M, Kanj M, Koepp S, Martin DO, Marrouche N, Mays J, Pryce J, Rozich R, Saliba W, Schweikert R, Sullivan JM, Sweeney DK, Semenec T, Spencer S, Tchou PJ, Wilkoff B, Macle L, Badra M, Barrero M, Bertrand G, Brugada R, Creo H, David D, Demoniere F, Dubuc M, Dumont F, Gagne P, Guerra P, Katsouras G, Khairy P, Lemola K, Mansour R, Proietti A, Rivard L, Roux JF, Roy D, Sylvain L, Talajic M, Thibault B, Daoud E, Augostini R, Chumita R, Dawson G, Hummel J, Kalbfleisch S, Daoud E, Augostini R, Bremer J, Chumita R, Dawson G, Crow K, Hummel J, Kalbfleisch S, Ryan J, Weiss R, Calkins H, Avara K, Berger R, Hawes C, Henrickson C, Marine J, Robinson E, Robinson G, Stack J, Hall B, Daubert J, Huang D, Patterson C, Pyykkonen K, Rosero S, Schrack J, Yeager C, Deville B, Weaver T, Williams D, Worley T, Hao S, Bartek L, Beheiry S, Bernier E, Carnam J, Hongo R, Im G, Voskyul J, Watanabe D, Weiss R, Swarup V, Arroyo N, Bahu M, Bodner G, Cataldo R, Ellingson N, Khanna P, Krebsbach A, Mattioni T, Ning A, Riggio D, Scrivano S, Tendler D, Williams C, Vandermate B, Fausett L, Steinberg J, Arshad A, Cotiga D, Ehlert F, Knox R, Pierce W, Friehling T, Bell MH, Blake M, Doctor A, Durrani SA, Del Negro AA, Strouse DA, Wish MH, Pollack S, Goodwin L, Harrison S, Monir G, Stastny C, John RM, Byrne JM, Hook BG, Martin DT, Michaud GF, Parrella FM, Wharton M, Clarke E, Schultz M (2010). Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. J Am Med Assoc, 303(4), 333-40.
  17. Badger TJ, Daccarett M, Akoum NW, Adjei-Poku YA, Burgon NS, Haslam TS, Kalvaitis S, Kuppahally S, Vergara G, McMullen L, Anderson PA, Kholmovski E, Macleod RS, Marrouche NF (2010). Evaluation of Left Atrial Lesions after Initial and Repeat Atrial Fibrillation Ablation: Lessons Learned from Delayed-Enhancement MRI in Repeat Ablation Procedures. Circ Arrhythm Electrophysiol, 3(3), 249-59.
  18. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, McGann CJ, Akoum N, Kholmovski E, Macleod RS, Marrouche NF (2010). Evaluation of the Left Atrial Substrate in Patients with Lone Atrial Fibrillation Using Delayed-Enhanced MRI: Implications for Disease Progression and Response to Catheter Ablation. Heart Rhythm, 7(10), 1475-85.
  19. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF (2010). Left Atrial Strain and Strain Rate in Patients with Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed Enhancement-MRI. Circ Cardiovasc Imaging, 3(3), 231-9.
  20. Segerson NM, Daccarett M, Badger TJ, Shabaan A, Akoum N, Fish EN, Rao S, Burgon NS, Adjei-Poku Y, Kholmovski E, Vijayakumar S, Dibella EV, Macleod RS, Marrouche NF (2010). Magnetic Resonance Imaging-Confirmed Ablative Debulking of the Left Atrial Posterior Wall and Septum for Treatment of Persistent Atrial Fibrillation: Rationale and Initial Experience. J Cardiovasc Electrophysiol, 21(2), 126-32.
  21. Vergara GR, Marrouche NF (2010). Tailored Management of Atrial Fibrillation Using a LGE-MRI Based Model: From the Clinic to the Electrophysiology Laboratory. J Cardiovasc Electrophysiol, 22(4), 481-7.
  22. Temporal left atrial lesion formation after ablation of atrial fibrillation.Badger TJ, Oakes RS, Daccarett M, Burgon NS, Akoum N, Fish EN, Blauer JJ, Rao SN, Adjei-Poku Y, Kholmovski EG, Vijayakumar S, Di Bella EV, Macleod RS, Marrouche NF (2009). Temporal left atrial lesion formation after ablation of atrial fibrillation. Heart Rhythm, 6(2), 161-8.
  23. Esophageal acid levels after pulmonary vein isolation for atrial fibrillation.Nolker G, Ritscher G, Gutleben KJ, Marschang H, Schmidt M, Rittger H, Mayer D, Marrouche N, Brachmann J, Sinha AM (2009). Esophageal acid levels after pulmonary vein isolation for atrial fibrillation. Pacing Clin Electrophysiol, 32 Suppl 1, S228-30.
  24. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy.Sinha AM, Schmidt M, Marschang H, Gutleben K, Ritscher G, Brachmann J, Marrouche NF (2009). Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol, 32(3), 286-90.
  25. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF (2009). Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation, 119(13), 1758-67.
  26. MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation.Badger TJ, Adjei-Poku YA, Marrouche NF (2009). MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation. Future Cardiol new, 5(1), 63-70.
  27. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design.Marrouche NF, Brachmann J (2009). Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design. Pacing Clin Electrophysiol, 32(8), 987-94.
  28. Atrial fibrillation ablation in patients with therapeutic international normalized ratios.Schmidt M, Segerson NM, Marschang H, Akoum N, Rittger H, Clifford SM, Brachmann J, Daccarett M, Marrouche NF (2009). Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol, 32(8), 995-9.
  29. Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation.Badger TJ, Adjei-Poku YA, Burgon NS, Kalvaitis S, Shaaban A, Sommers DN, Blauer JJ, Fish EN, Akoum N, Haslem TS, Kholmovski EG, MacLeod RS, Adler DG, Marrouche NF (2009). Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation. Circ Arrhythm Electrophysiol, 2(6), 620-5.
  30. Incidence of oesophageal wall injury post-pulmonary vein antrum isolation for treatment of patients with atrial fibrillation.Schmidt M, Nolker G, Marschang H, Gutleben KJ, Schibgilla V, Rittger H, Sinha AM, Ritscher G, Mayer D, Brachmann J, Marrouche NF (2008). Incidence of oesophageal wall injury post-pulmonary vein antrum isolation for treatment of patients with atrial fibrillation. Europace, 10(2), 205-9.
  31. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation.McGann CJ, Kholmovski EG, Oakes RS, Blauer JJ, Daccarett M, Segerson N, Airey KJ, Akoum N, Fish E, Badger TJ, DiBella EV, Parker D, MacLeod RS, Marrouche NF (2008). New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol, 52(15), 1263-71.
  32. Atrial flutter ablation in inducible patients during pulmonary vein atrum isolation: a randomized comparison.Schmidt M, Daccarett M, Segerson N, Airey KJ, Gunther J, Marschang H, Fish E, Rittger H, Sinha AM, Ritscher G, Brachmann J, Marrouche NF (2008). Atrial flutter ablation in inducible patients during pulmonary vein atrum isolation: a randomized comparison. Pacing Clin Electrophysiol, 31(12), 1592-7.
  33. Three-dimensional left atrial and esophagus reconstruction using cardiac C-arm computed tomography with image integration into fluoroscopic views for ablation of atrial fibrillation: accuracy of a novel modality in comparison with multislice computed tomography.Nolker G, Gutleben KJ, Marschang H, Ritscher G, Asbach S, Marrouche N, Brachmann J, Sinha AM (2008). Three-dimensional left atrial and esophagus reconstruction using cardiac C-arm computed tomography with image integration into fluoroscopic views for ablation of atrial fibrillation: accuracy of a novel modality in comparison with multislice computed tomography. Heart Rhythm, 5(12), 1651-7.
  34. Real-time imaging in left atrial mapping and ablation.Daccarett M, Oakes R, Segerson NM, Windfelder J, Marrouche NF (2008). Real-time imaging in left atrial mapping and ablation. Future Cardiol, 4(3), 253-60.
  35. Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury.Marrouche NF, Guenther J, Segerson NM, Daccarett M, Rittger H, Marschang H, Schibgilla V, Schmidt M, Ritscher G, Noelker G, Brachmann J (2007). Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol, 18(6), 583-8.
  36. Using the initial vector from surface electrocardiogram to distinguish the site of outflow tract tachycardia.Yang Y, Saenz LC, Varosy PD, Badhwar N, Tan JH, Kilicaslan F, Keung EC, Natale A, Marrouche NF, Scheinman MM (2007). Using the initial vector from surface electrocardiogram to distinguish the site of outflow tract tachycardia. Pacing Clin Electrophysiol, 30(7), 891-8.
  37. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.Ellis K, Wazni O, Marrouche N, Martin D, Gillinov M, McCarthy P, Saad EB, Bhargava M, Schweikert R, Saliba W, Bash D, Rossillo A, Erciyes D, Tchou P, Natale A (2007). Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol, 18(8), 799-802.
  38. Blinded correlation study of three-dimensional electro-anatomical image integration and phased array intra-cardiac echocardiography for left atrial mapping.Daccarett M, Segerson NM, Gunther J, Nolker G, Gutleben K, Brachmann J, Marrouche NF (2007). Blinded correlation study of three-dimensional electro-anatomical image integration and phased array intra-cardiac echocardiography for left atrial mapping. Europace, 9(10), 923-6.
  39. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.Verma A, Kilicaslan F, Martin DO, Minor S, Starling R, Marrouche NF, Almahammed S, Wazni OM, Duggal S, Zuzek R, Yamaji H, Cummings J, Chung MK, Tchou PJ, Natale A (2006). Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart, 92(2), 190-5.
  40. Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation?Gillinov AM, Bakaeen F, McCarthy PM, Blackstone EH, Rajeswaran J, Pettersson G, Sabik JF 3rd, Najam F, Hill KM, Svensson LG, Cosgrove DM, Marrouche N, Natale A (2006). Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation? Ann Thorac Surg, 81(1), 19-26; discussion 27-8.
  41. Avoiding microbubbles formation during radiofrequency left atrial ablation versus continuous microbubbles formation and standard radiofrequency ablation protocols: comparison of energy profiles and chronic lesion characteristics.Oh S, Kilicaslan F, Zhang Y, Wazni O, Mazgalev TN, Natale A, Marrouche NF (2006). Avoiding microbubbles formation during radiofrequency left atrial ablation versus continuous microbubbles formation and standard radiofrequency ablation protocols: comparison of energy profiles and chronic lesion characteristics. J Cardiovasc Electrophysiol, 17(1), 72-7.
  42. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.Kilicaslan F, Verma A, Saad E, Themistoclakis S, Bonso A, Raviele A, Bozbas H, Andrews MW, Beheiry S, Hao S, Cummings JE, Marrouche NF, Lakkireddy D, Wazni O, Yamaji H, Saenz LC, Saliba W, Schweikert RA, Natale A (2006). Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm, 3(3), 275-80.
  43. Kilicaslan F, Verma A, Saad E, Rossillo A, Davis DA, Prasad SK, Wazni O, Marrouche NF, Raber LN, Cummings JE, Beheiry S, Hao S, Burkhardt JD, Saliba W, Schweikert RA, Martin DO, Natale A (2006). Transcranial Doppler detection of microembolic signals during pulmonary vein antrum isolation: implications for titration of radiofrequency energy. J Cardiovasc Electrophysiol, 17(5), 495-501.
  44. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN (2006). Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm, 3(6), 701-8.
  45. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure.Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A (2005). Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol, 45(2), 285-92.
  46. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator.Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, Natale A, Martin DO (2005). Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol, 95(4), 490-1.
  47. Response to pharmacological challenge of dissociated pulmonary vein rhythm.Marrouche N, Wazni OM, Martin DO, Rossillo A, Saliba W, Erciyes D, Schweikert R, Khaykin Y, Burkhardt D, Bhargava M, Verma A, Abdul-Karim A, Natale A (2005). Response to pharmacological challenge of dissociated pulmonary vein rhythm. J Cardiovasc Electrophysiol, 16(2), 122-6.
  48. The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery.Kilicaslan F, Verma A, Yamaji H, Marrouche NF, Wazni O, Cummings JE, Hao S, Andrews MW, Beheiry S, Abdul-Karim A, Belden WA, Minor S, Burkhardt JD, Saliba W, Schweikert RA, Natale A (2005). The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery. J Am Coll Cardiol, 45(5), 690-6.
  49. Left atrial flutter following pulmonary vein antrum isolation with radiofrequency energy: linear lesions or repeat isolation.Cummings JE, Schweikert R, Saliba W, Hao S, Martin DO, Marrouche NF, Burkhardt JD, Kilicaslan F, Verma A, Beheiry S, Belden W, Natale A (2005). Left atrial flutter following pulmonary vein antrum isolation with radiofrequency energy: linear lesions or repeat isolation. J Cardiovasc Electrophysiol, 16(3), 293-7.
  50. Usefulness of Doppler assessment of pulmonary vein and left atrial appendage flow following pulmonary vein isolation of chronic atrial fibrillation in predicting recovery of left atrial function.Donal E, Grimm RA, Yamada H, Kim YJ, Marrouche N, Natale A, Thomas JD (2005). Usefulness of Doppler assessment of pulmonary vein and left atrial appendage flow following pulmonary vein isolation of chronic atrial fibrillation in predicting recovery of left atrial function. Am J Cardiol, 95(8), 941-7.
  51. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction.Verma A, Marrouche NF, Schweikert RA, Saliba W, Wazni O, Cummings J, Abdul-Karim A, Bhargava M, Burkhardt JD, Kilicaslan F, Martin DO, Natale A (2005). Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol, 16(5), 465-71.
  52. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.Wazni O, Martin DO, Marrouche NF, Shaaraoui M, Chung MK, Almahameed S, Schweikert RA, Saliba WI, Natale A (2005). C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart, 91(10), 1303-5.
  53. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A (2005). Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA, 293(21), 2634-40.
  54. Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality.Gillinov AM, McCarthy PM, Blackstone EH, Rajeswaran J, Pettersson G, Sabik JF, Svensson LG, Cosgrove DM, Hill KM, Gonzalez-Stawinski GV, Marrouche N, Natale A (2005). Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality. J Thorac Cardiovasc Surg, 129(6), 1322-9.
  55. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging.Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M, Bash D, Beheiry S, Wexman M, Potenza D, Pisano E, Fanelli R, Bonso A, Themistoclakis S, Erciyes D, Saliba WI, Schweikert RA, Brachmann J, Raviele A, Natale A (2005). Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol, 16(6), 576-81.
  56. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A (2005). Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation, 111(24), 3209-16.
  57. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction.Verma A, Kilicaslan F, Pisano E, Marrouche NF, Fanelli R, Brachmann J, Geunther J, Potenza D, Martin DO, Cummings J, Burkhardt JD, Saliba W, Schweikert RA, Natale A (2005). Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation, 112(5), 627-35.
  58. The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation.Gillinov AM, Sirak J, Blackstone EH, McCarthy PM, Rajeswaran J, Pettersson G, Sabik FJ 3rd, Svensson LG, Navia JL, Cosgrove DM, Marrouche N, Natale A (2005). The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg, 130(6), 1653-60.
  59. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter:.Bhargava M, Marrouche NF, Martin DO, Schweikert RA, Saliba W, Saad EB, Bash D, Williams-Andrews M, Rossillo A, Erciyes D, Khaykin Y, Burkhardt JD, Joseph G, Tchou PJ, Natale A (2004). Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter:. J Cardiovasc Electrophysiol, 15(1), 8-13.
  60. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M, Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-Lugones A, Abdul-Karim A, Saliba W, Natale A (2004). Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol, 43(6), 1004-9.
  61. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W, Kilicaslan F, Cummings J, Burkhardt JD, Bhargava M, Bash D, Brachmann J, Guenther J, Hao S, Beheiry S, Rossillo A, Raviele A, Themistoclakis S, Natale A (2004). Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol, 43(9), 1715-20.
  62. Left septal atrial flutter: electrophysiology, anatomy, and results of ablation.Marrouche NF, Natale A, Wazni OM, Cheng J, Yang Y, Pollack H, Verma A, Ursell P, Scheinman MM (2004). Left septal atrial flutter: electrophysiology, anatomy, and results of ablation. Circulation, 109(20), 2440-7.
  63. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, Schweikert RA, Saliba WI, Gillinov AM, Tang WH, Mills RM, Francis GS, Young JB, Natale A (2004). Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation, 110(2), 124-7.
  64. Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.Khaykin Y, Marrouche NF, Martin DO, Saliba W, Schweikert R, Wexman M, Strunk B, Beheiry S, Saad E, Bhargava M, Burkhardt JD, Joseph G, Tchou P, Natale A (2004). Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses. J Cardiovasc Electrophysiol, 15(7), 784-9.
  65. Importance of ablating all potential right atrial flutter circuits in postcardiac surgery patients.Verma A, Marrouche NF, Seshadri N, Schweikert RA, Bhargava M, Burkhardt JD, Kilicaslan F, Cummings J, Saliba W, Natale A (2004). Importance of ablating all potential right atrial flutter circuits in postcardiac surgery patients. J Am Coll Cardiol, 44(2), 409-14.
  66. Novel method to integrate three-dimensional computed tomographic images of the left atrium with real-time electroanatomic mapping.Verma A, Marrouche N, Natale A (2004). Novel method to integrate three-dimensional computed tomographic images of the left atrium with real-time electroanatomic mapping. J Cardiovasc Electrophysiol, 15(8), 968.
  67. Usefulness of intracardiac Doppler assessment of left atrial function immediately post-pulmonary vein antrum isolation to predict short-term recurrence of atrial fibrillation.Verma A, Marrouche NF, Yamada H, Grimm RA, Cummings J, Burkhardt JD, Kilicaslan F, Bhargava M, Karim AA, Thomas JD, Natale A (2004). Usefulness of intracardiac Doppler assessment of left atrial function immediately post-pulmonary vein antrum isolation to predict short-term recurrence of atrial fibrillation. Am J Cardiol, 94(7), 951-4.
  68. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up.Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, Golshayan AR, McCurdy R, Bhargava M, Khaykin Y, Burkhardt JD, Martin DO, Wilkoff BL, Saliba WI, Schweikert RA, Raviele A, Natale A (2004). Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol, 15(10), 1120-5.
  69. Potential role of body surface ECG mapping for localization of atrial fibrillation trigger sites.Sippensgroenewegen A, Natale A, Marrouche NF, Bash D, Cheng J (2004). Potential role of body surface ECG mapping for localization of atrial fibrillation trigger sites. J Electrocardiol, 37 Suppl, 47-52.
  70. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm.Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Karim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A (2004). Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol, 15(11), 1265-70.
  71. Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique.Verma A, Marrouche NF, Natale A (2004). Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol, 15(11), 1335-40.
  72. Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery.Khaykin Y, Marrouche NF, Saliba W, Schweikert R, Bash D, Chen MS, Williams-Andrews M, Saad E, Burkhardt DJ, Bhargava M, Joseph G, Rossillo A, Erciyes D, Martin D, Natale A (2004). Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm, 1(1), 33-9.
  73. Three-dimensional reconstruction of pulmonary veins in patients with atrial fibrillation and controls: morphological characteristics of different veins.Perez-Lugones A, Schvartzman PR, Schweikert R, Tchou PJ, Saliba W, Marrouche NF, Castle LW, White RD, Natale A (2003). Three-dimensional reconstruction of pulmonary veins in patients with atrial fibrillation and controls: morphological characteristics of different veins. Pacing Clin Electrophysiol, 26(1 Pt 1), 8-15.
  74. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome.Saad EB, Marrouche NF, Saad CP, Ha E, Bash D, White RD, Rhodes J, Prieto L, Martin DO, Saliba WI, Schweikert RA, Natale A (2003). Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med, 138(8), 634-8.
  75. Use of different catheter ablation technologies for treatment of typical atrial flutter: acute results and long-term follow-up.Marrouche NF, Schweikert R, Saliba W, Pavia SV, Martin DO, Dresing T, Cole C, Balaban K, Saad E, Perez-Lugones A, Bash D, Tchou P, Natale A (2003). Use of different catheter ablation technologies for treatment of typical atrial flutter: acute results and long-term follow-up. Pacing Clin Electrophysiol, 26(3), 743-6.
  76. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications.Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W, Natale A (2003). Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation, 107(21), 2710-6.
  77. Surface electrocardiographic characteristics of right and left atrial flutter.Bochoeyer A, Yang Y, Cheng J, Lee RJ, Keung EC, Marrouche NF, Natale A, Scheinman MM (2003). Surface electrocardiographic characteristics of right and left atrial flutter. Circulation, 108(1), 60-6.
  78. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations.Schweikert RA, Saliba WI, Tomassoni G, Marrouche NF, Cole CR, Dresing TJ, Tchou PJ, Bash D, Beheiry S, Lam C, Kanagaratnam L, Natale A (2003). Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation, 108(11), 1329-35.
  79. Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation.Qureshi AM, Prieto LR, Latson LA, Lane GK, Mesia CI, Radvansky P, White RD, Marrouche NF, Saad EB, Bash DL, Natale A, Rhodes JF (2003). Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. Circulation, 108(11), 1336-42.
  80. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.Wazni O, Marrouche NF, Martin DO, Gillinov AM, Saliba W, Saad E, Klein A, Bhargava M, Bash D, Schweikert R, Erciyes D, Abdul-Karim A, Brachman J, Gunther J, Pisano E, Potenza D, Fanelli R, Natale A (2003). Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation, 108(20), 2479-83.
  81. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D, Bash D, Williams-Andrews M, Beheiry S, Marrouche NF, Adams J, Pisano E, Fanelli R, Potenza D, Raviele A, Bonso A, Themistoclakis S, Brachmann J, Saliba WI, Schweikert RA, Natale A (2003). Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation, 108(25), 3102-7.
  82. Martin DO, Saliba W, McCarthy PM, Gillinov AM, Belden W, Marrouche NF, Natale A (2003). Approaches to restoring and maintaining normal sinus rhythm. Cleve Clin J Med, 70(Suppl 3), S12-29.
  83. Perez-Lugones A, McMahon JT, Ratliff NB, Saliba WI, Schweikert RA, Marrouche NF, Saad EB, Navia JL, McCarthy PM, Tchou P, Gillinov AM, Natale A (2003). Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol, 14(8), 803-9.
  84. Seshadri N, Marrouche NF, Wilber D, Packer D, Natale A (2003). Pulmonary vein isolation for treatment of atrial fibrillation: recent updates. Pacing Clin Electrophysiol, 26(7 Pt 2), 1636-40.

Review

  1. Han F, Akoum N, and Marrouche N (10/01/2013). Value of Magnetic Resonance Imaging in Guiding Atrial Fibrillation Management. [Review]. Canadian Journal of Cardiology, 29(10), 1194-1202.
  2. Ablation of atrial fibrillation.Riley MJ, Marrouche NF (2006). Ablation of atrial fibrillation. [Review]. Curr Probl Cardiol, 31(5), 361-90.
  3. Novel applications in catheter ablation.Thal SG, Marrouche NF (2005). Novel applications in catheter ablation. [Review]. J Interv Card Electrophysiol, 13 Suppl 1, 17-21.
  4. Contemporary surgical treatment for atrial fibrillation.Gillinov AM, McCarthy PM, Marrouche N, Natale A (2003). Contemporary surgical treatment for atrial fibrillation. [Review]. Pacing Clin Electrophysiol, 26(7 Pt 2), 1641-4.
  5. Ablation of focal atrial fibrillation.Saad EB, Marrouche NF, Natale A (2002). Ablation of focal atrial fibrillation. [Review]. Card Electrophysiol Rev, 6(4), 389-96.
  6. Evaluation and management of ventricular outflow tract tachycardias.Cole CR, Marrouche NF, Natale A (2002). Evaluation and management of ventricular outflow tract tachycardias. [Review]. Card Electrophysiol Rev, 6(4), 442-7.

Case Report

  1. Ablation of atrial flutter by the femoral approach in the absence of inferior vena cava.Guenther J, Marrouche N, Ruef J (2007). Ablation of atrial flutter by the femoral approach in the absence of inferior vena cava. Europace, 9(11), 1073-4.
  2. Asymptomatic acute inferior ST elevation myocardial infarction from thermal injury complicating radiofrequency ablation for atrioventricular re-entrant tachycardia.Chacko M, Marrouche NF, Bhatt DL (2004). Asymptomatic acute inferior ST elevation myocardial infarction from thermal injury complicating radiofrequency ablation for atrioventricular re-entrant tachycardia. J Invasive Cardiol, 16(9), 504-5.
  3. Moricizine induced increase in pacing threshold.Girod JP, Marrouche N, Chen MS, Natale A (2003). Moricizine induced increase in pacing threshold. Pacing Clin Electrophysiol, 26(1 Pt 1), 110-1.
  4. Incessant nonreentrant tachycardia due to simultaneous conduction over dual atrioventricular nodal pathways mimicking atrial fibrillation in patients referred for pulmonary vein isolation.Mansour M, Marrouche N, Ruskin J, Natale A, Keane D (2003). Incessant nonreentrant tachycardia due to simultaneous conduction over dual atrioventricular nodal pathways mimicking atrial fibrillation in patients referred for pulmonary vein isolation. J Cardiovasc Electrophysiol, 14(7), 752-5.

Editorial

  1. Still Looking for the Right Mechanism as a Target During Ablation of Atrial Fibrillation.LID - 10.1111/j.1540-8167.2012.02303.x [doi]Higuchi K, Marrouche NF (2012). Still Looking for the Right Mechanism as a Target During Ablation of Atrial Fibrillation.LID - 10.1111/j.1540-8167.2012.02303.x [doi]. J Cardiovasc Electrophysiol.
  2. Cardiac magnetic resonance in the world of the cardiac electrophysiologist: the road to real-time cardiac magnetic resonance.Pandit A, Marrouche NF (2009). Cardiac magnetic resonance in the world of the cardiac electrophysiologist: the road to real-time cardiac magnetic resonance. JACC Cardiovasc Imaging, 2(3), 317-8.
  3. Real-time imaging in electrophysiology: from intra-cardiac echo to real-time magnetic resonance imaging.Akoum N, Marrouche NF (2009). Real-time imaging in electrophysiology: from intra-cardiac echo to real-time magnetic resonance imaging. Europace, 11(5), 539-40.
  4. Towards optimization of imaging for ablation of atrial fibrillation: the search for a gold standard.Segerson N, Lim T, Marrouche NF (2008). Towards optimization of imaging for ablation of atrial fibrillation: the search for a gold standard. Heart Rhythm, 5(7), 965-7.

Clinical Trials

Clinical Trials

  • CADENCE
    Keywords: OPC-108459, atrial fibrillation
    Status: Recruiting Principal Investigator: Nazem Akoum

Video & News